Kt. Mok et Hc. Meng, INTESTINAL, PANCREATIC, AND HEPATIC-EFFECTS OF GASTROINTESTINAL HORMONES IN A TOTAL PARENTERAL-NUTRITION RAT MODEL, JPEN. Journal of parenteral and enteral nutrition, 17(4), 1993, pp. 364-369
The adverse effects of long-term total parenteral nutrition (TPN) are
well documented. Lack of gastrointestinal (GI) stimulation from oral f
eeding, reduction of GI hormone secretion, and interruption of enteroh
epatic circulation of bile may be found. TPN results in atrophy of the
digestive system, intestinal bacterial overgrowth and translocation,
liver cell damage, and gallstone formation. In addition, the increase
incidence of sepsis of gut origin may lead to an increase in mortality
. In some studies, results of the administration of GI hormones to pat
ients receiving prolonged TPN suggest the possibility of reducing some
of the adverse effects of long-term TPN. To evaluate the role of GI h
ormone in the prevention of adverse effects of TPN, we designed the fo
llowing study: 50 young adult male Wistar rats, weighing approximately
200 g, were divided into five equal groups. All animals received iden
tical TPN infusate for 7 days. GI hormone was added to the TPN infusat
e as follows: Group A (control) received no GI hormone, group B was gi
ven glucagon at a dosage of 330 mug/kg per day, group C was administer
ed cholecystokinin 2 Ivy dog units twice a day, group D received secre
tin 2 clinical units twice a day, and group E was given both cholecyst
okinin and secretin at the dosages stated for groups C and D. Maintena
nce of mucosal brush-border hydrolase activity was found in group B. N
either atrophy of the pancreas nor hypoplasia of intestinal villi was
observed in groups C and D. Group C showed improvement of liver functi
on-associated tests, better weight gain, and acceleration of enterohep
atic circulation of bile. Mucosal weight and DNA contents were increas
ed in group D, and acceleration of cholesterol catabolism was found in
group E. We concluded that cholecystokinin seems capable of preventin
g some adverse effects of 7-day TPN treatment on the GI system. The be
nefit of glucagon or secretin administration was limited.